| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.19 | 0.3 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |